Zobrazeno 1 - 10
of 364
pro vyhledávání: '"bpdcn"'
Autor:
Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya, Anthony S. Stein, Soheil Meshinchi, Craig A. Mullen, Emanuele Angelucci, Luciana Vinti, Tariq I. Mughal, Anna B. Pawlowska
Publikováno v:
eJHaem, Vol 5, Iss 1, Pp 61-69 (2024)
Abstract Blastic plasmacytoid dendritic cell neoplasm (BPDCN) predominantly occurs in adults ≥60 years old; 10–20% of cases are pediatric or adolescent/young adult (AYA) patients. Tagraxofusp (TAG, Elzonris®) is the only approved treatment for B
Externí odkaz:
https://doaj.org/article/f0c19f1aedd446e39c2ceaabeb4efd0f
Publikováno v:
Clinical Case Reports, Vol 12, Iss 9, Pp n/a-n/a (2024)
Key Clinical Message Blastic plasmacytoid dendritic cell neoplasm is a rare hematologic malignancy and appropriate diagnosis encounters difficulties in both clinical and pathologic aspects. This case report aims to present a clinical case to help fam
Externí odkaz:
https://doaj.org/article/5a1884757a6543b0ab3d2bd1b05fe366
Autor:
Gerardo Cazzato, Marialessandra Capuzzolo, Emilio Bellitti, Giovanni De Biasi, Anna Colagrande, Katia Mangialardi, Francesco Gaudio, Giuseppe Ingravallo
Publikováno v:
Hematology Reports, Vol 15, Iss 4, Pp 696-706 (2023)
Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCNs) are a rare, highly aggressive hematological malignant neoplasm that primarily involve the skin, bone marrow, lymph nodes and even extra-nodal sites. The rarity and relative poor description of ca
Externí odkaz:
https://doaj.org/article/1c54c07c7cd64e23a398b72955d8d82a
Autor:
Christopher J. Fay, BA, Christopher Iriarte, MD, Dorsa Moslehi, BA, Anthony R. Sheets, MD, PhD, Nicole R. LeBoeuf, MD, MPH
Publikováno v:
JAAD Case Reports, Vol 39, Iss , Pp 70-73 (2023)
Externí odkaz:
https://doaj.org/article/0daefdc8fbfc439b9f313aad37b771ca
Autor:
Philipp Faustmann, Jan C. Schroeder, Lucas Mix, Lennart Harland, Andreas Riedel, Wichard Vogel, Claudia Lengerke, Stefan Wirths
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionBlastic plasmacytoid dendritic cell neoplasia (BPDCN) is a rare, aggressive hematologic malignancy. Until recently, the only curative treatment consisted of intensive chemotherapy, followed by hematopoietic cell transplantation (HCT) in e
Externí odkaz:
https://doaj.org/article/59436f179743470f8f93e14d69f715f2
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11284-11292 (2023)
Abstract Background Previous studies had explored the diagnostic or prognostic value of NRP‐1/CD304 in blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute myeloid leukemia (AML), and B‐cell acute lymphoblastic leukemia (B‐ALL), whereas
Externí odkaz:
https://doaj.org/article/23ebc2f8db194472994e6b850b3758cd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Leukemia Research Reports, Vol 22, Iss , Pp 100486- (2024)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a rare and often life-threatening complex hematologic malignancy that can commonly infiltrate the skin, lymph nodes, central nervous system, and bone marrow. In the setting of the infrequency of
Externí odkaz:
https://doaj.org/article/7a4ba092ff6b4a69831d4d9b16fcb0de
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lifang Huang, Fan Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and poorly understood hematopoietic malignancy. This study aimed to investigate the clinical characteristics and prognostic factors in patients with primary BPDCN.MethodsPatient
Externí odkaz:
https://doaj.org/article/53692e98954f4e52b7d77ac16c13e9c8